Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,009–3,016 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Novartis AG Felzartamab (MOR202) - (IGNAZ) Immunoglobulin A Nephropathy (IgAN) - Berger's disease Phase 2 Ongoing Intravenous #N/A
Novartis AG FCR001 - (FREEDOM-3) Scleroderma Phase 2 Clinical Pause Intravenous Immunology
Novartis AG ECF843 Dry Eye Disease Phase 2 Trial Discontinued topical ophthalmic Opthalmic
Novartis AG Atrasentan - (AFFINITY) Chronic kidney disease Phase 2 Ongoing Oral N/A
Novartis AG MOR208 + idelalisib (COSMOS) Chronic Lymphocytic Leukemia Phase 2 Ongoing Intravenous Oncology
Novavax Inc. NVX-CoV2373 COVID-19 vaccine BLA Filing Ongoing Intramuscular COVID-19
Novavax Inc. 2019nCoV-415 (Adjuvanted 2024-2025 Formula) - (SHIELD) COVID-19 Vaccine Phase 3 Data Released Intramuscular injection COVID-19
Novavax Inc. COVID-19 vaccine (NVX-CoV2705) COVID-19-Influenza Combination (CIC) 2024-2025 Phase 3 Ongoing Intramuscular COVID-19